• 4
  • 3
  • 1

NANOMED DEVELOPS A NEW INNOVATIVE TREATMENT FOR ATRIAL FIBRILLATION



NanoMed Targeting Systems (NTS) is an early stage company founded in Oklahoma City, OK. NTS’s mission and focus is to develop, manufacture and market magnetically targeted drug delivery systems. The platform system is based on proprietary magnetic nanoformulations attached to therapeutic payload(s), and its non-invasive proprietary magnetic guiding system. NTS is currently working on Targeting System to treat Atrial Fibrillation, the most common cardiac arrhythmia.
nanomed-systems